Leerink analyst Daniel Clark raised the firm’s price target on Elanco (ELAN) to $30 from $26 and keeps an Outperform rating on the shares. The firm says the company ended 2025 with a flourish, exceeding top and bottom-line expectations in Q4. The company is firing on all cylinders, seeing growth from all segments and geographies, led by its innovative products, Leerink adds. The company’s differentiated products continue to gain share, and have plenty of runway ahead.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Morning Movers: Intuit climbs following AI agent partnership with Anthropic
- Elanco Animal Health: Innovation-Led Growth and Conservative Guidance Support Buy Rating and Attractive Risk/Reward
- Elanco reports Q4 adjusted EPS 13c, consensus 11c
- Elanco sees FY26 adjusted EPS $1.00-$1.06, consensus $1.03
- Notable companies reporting before tomorrow’s open